Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: A network meta-analysis of 11 randomized, controlled trials

JACC: Cardiovascular Interventions

Volumn 8, Issue 3, 2015, Pages 382-394

  Lee, Joo Myung ^a   Park, Jonghanne ^a   Kang, Jeehoon ^a   Jeon, Ki Hyun ^a   Jung, Ji Hyun ^a   Lee, Sang Eun ^a   Han, Jung Kyu ^a   Kim, Hack Lyoung ^b   Yang, Han Mo ^a   Park, Kyung Woo ^a   Kang, Hyun Jae ^a   Koo, Bon Kwon ^a   Kim, Hyo Soo ^a,c  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

controlled trial; drug eluting balloons; drug eluting stents; in stent restenosis; meta analysis; randomized

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN; BIOMATERIAL;

ANGIOGRAPHY; ARTICLE; BALLOON; BARE METAL STENT; COMPARATIVE EFFECTIVENESS; DEVICE SAFETY; DRUG ELUTING BALLOON; DRUG ELUTING CORONARY STENT; DRUG ELUTING STENT; HEART DISEASE; HUMAN; IN-STENT RESTENOSIS; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLAIN OLD BALLOON ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; ADVERSE EFFECTS; BAYES THEOREM; CORONARY RESTENOSIS; DEVICES; HEART CATHETER; MYOCARDIAL INFARCTION; ODDS RATIO; PROSTHESIS; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; BAYES THEOREM; CARDIAC CATHETERS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 84926407357     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.09.023     Document Type: Article

References (27)

1. F. Alfonso, R.A. Byrne, F. Rivero, and A. Kastrati Current treatment of in-stent restenosis J Am Coll Cardiol 63 2014 2659 2673
2. G.D. Dangas, B.E. Claessen, A. Caixeta, E.A. Sanidas, G.S. Mintz, and R. Mehran In-stent restenosis in the drug-eluting stent era J Am Coll Cardiol 56 2010 1897 1907
3. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
4. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC), the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI) Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
5. B. Scheller, C. Hehrlein, and W. Bocksch Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
6. B. Scheller, C. Hehrlein, and W. Bocksch Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin Res Cardiol 97 2008 773 781
7. M. Unverdorben, C. Vallbracht, and B. Cremers Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2009 2986 2994
8. A. Kastrati, J. Mehilli, and N. von Beckerath Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial JAMA 293 2005 165 171
9. F. Alfonso, M.J. Perez-Vizcayno, and R. Hernandez Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: balloon angioplasty vs. elective sirolimus-eluting Stenting) study J Am Coll Cardiol 52 2008 1621 1627
10. S. Habara, K. Mitsudo, and K. Kadota Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis J Am Coll Cardiol Intv 4 2011 149 154
11. H. Rittger, J. Brachmann, and A.M. Sinha A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J Am Coll Cardiol 59 2012 1377 1382
12. B. Scheller, Y.P. Clever, and B. Kelsch Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter J Am Coll Cardiol Intv 5 2012 323 330
13. F. Alfonso, M.J. Perez-Vizcayno, and A. Cardenas A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent) J Am Coll Cardiol 63 2014 1378 1386
14. R.A. Byrne, F.J. Neumann, and J. Mehilli Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 381 2013 461 467
15. S. Habara, M. Iwabuchi, and N. Inoue A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis Am Heart J 166 2013 527 533
16. B. Xu, R. Gao, and J. Wang A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial J Am Coll Cardiol Intv 7 2014 204 211
17. B. Chevalier, R. Moulichon, and E. Teiger One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents J Interv Cardiol 25 2012 586 595
18. F. Alfonso, M.J. Perez-Vizcayno, and R. Hernandez A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial J Am Coll Cardiol 47 2006 2152 2160
19. F. Alfonso, M.J. Perez-Vizcayno, and A. Cardenas A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent in-stent restenosis: the RIBS V clinical trial J Am Coll Cardiol 63 2014 1378 1386
20. K.W. Park, I.H. Chae, and D.S. Lim Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial J Am Coll Cardiol 58 2011 1844 1854
21. K.W. Park, J.M. Lee, and S.H. Kang Safety and efficacy of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice: patient-related and stent-related outcomes from the multicenter prospective EXCELLENT and RESOLUTE-Korea registries J Am Coll Cardiol 61 2013 536 544
22. M. Taniwaki, G.G. Stefanini, and S. Silber Four Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New Generation Drug-Eluting Stents in the RESOLUTE All Comers Randomized Trial J Am Coll Cardiol 63 2014 1617 1625
23. P.W. Serruys, V. Farooq, and B. Kalesan Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial J Am Coll Cardiol Intv 6 2013 777 789
24. S.J. Park, S.J. Kang, R. Virmani, M. Nakano, and Y. Ueda In-stent neoatherosclerosis: a final common pathway of late stent failure J Am Coll Cardiol 59 2012 2051 2057
25. A. Indermuehle, R. Bahl, and A.J. Lansky Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials Heart 99 2013 327 333
26. E.P. Navarese, D. Austin, and P.A. Gurbel Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials Clin Res Cardiol 102 2013 279 287
27. S.H. Kang, K.W. Park, and D.Y. Kang Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis Eur Heart J 35 2014 1147 1158